The results of sequential therapeutic trials in hospitalized manic pat
ients conducted over a le-year period are summarized, followed by an a
nalysis of pooled data to assess relative efficacy. No clinically impo
rtant baseline differences were found in the patients admitted to thes
e studies despite the long time span. They were not overly ''difficult
to treat'' or treatment resistant, and most were discharged to the co
mmunity. Nearly all outcome measures showed statistically significant
differences between groups after 8 weeks of treatment. The best respon
ses occurred in the patients who received a mean series of nine electr
oconvulsive therapy (ECT) treatments with sparing use of neuroleptics
followed by lithium maintenance. The next best outcome was observed wi
th lithium combined with low doses of standard neuroleptics or risperi
done. The combination of carbamazepine and lithium had significantly f
ewer neurological side effects than moderate doses of haloperidol with
lithium, with equivalent therapeutic results. Monotherapy with either
lithium or carbamazepine was less effective than the combination trea
tments. Minor differences in study design may contribute to the varian
ce in outcome.